{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:43:25Z","timestamp":1776343405202,"version":"3.51.2"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Science and Technology Planning Project","award":["No. 2024A04J4878"],"award-info":[{"award-number":["No. 2024A04J4878"]}]},{"name":"Guangzhou Science and Technology Planning Project","award":["No. 2024A04J9993"],"award-info":[{"award-number":["No. 2024A04J9993"]}]},{"name":"President Foundation of Zhujiang Hospital, Southern Medical University","award":["No. yzjj2022qn11"],"award-info":[{"award-number":["No. yzjj2022qn11"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82103668"],"award-info":[{"award-number":["No. 82103668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00945-8","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:15:22Z","timestamp":1773134122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging proteomics and machine learning for mechanism and biomarker discovery on glioma progression and transformation: from LGG to GBM"],"prefix":"10.1186","volume":"20","author":[{"given":"Qinhong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenbao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiquan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"7","key":"945_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387. https:\/\/doi.org\/10.1001\/jama.2023.0023.","journal-title":"JAMA"},{"issue":"8","key":"945_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"issue":"10412","key":"945_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/s0140-6736(23)01054-1","volume":"402","author":"MJ van den Bent","year":"2023","unstructured":"van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, et al. Primary brain tumours in adults. Lancet. 2023;402(10412):1564\u201379. https:\/\/doi.org\/10.1016\/s0140-6736(23)01054-1.","journal-title":"Lancet"},{"issue":"7","key":"945_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, et al. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016;48(7):768\u201376. https:\/\/doi.org\/10.1038\/ng.3590.","journal-title":"Nat Genet"},{"issue":"26","key":"945_CR5","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1402121.","journal-title":"N Engl J Med"},{"issue":"1","key":"945_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ng.3457","volume":"48","author":"H Bai","year":"2016","unstructured":"Bai H, Harmanc\u0131 AS, Erson-Omay EZ, Li J, Co\u015fkun S, Simon M, et al. Integrated genomic characterization of IDH1-mutant glioma malignant progression. Nat Genet. 2016;48(1):59\u201366. https:\/\/doi.org\/10.1038\/ng.3457.","journal-title":"Nat Genet"},{"issue":"6","key":"945_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1227\/neu.0000000000000580","volume":"75","author":"RR Zhang","year":"2014","unstructured":"Zhang RR, Pointer KB, Kuo JS, Dempsey RJ. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Neurosurgery. 2014;75(6):9\u201310. https:\/\/doi.org\/10.1227\/neu.0000000000000580.","journal-title":"Neurosurgery"},{"issue":"3","key":"945_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccell.2015.07.012","volume":"28","author":"T Mazor","year":"2015","unstructured":"Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, et al. DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors. Cancer Cell. 2015;28(3):307\u201317. https:\/\/doi.org\/10.1016\/j.ccell.2015.07.012.","journal-title":"Cancer Cell"},{"issue":"40","key":"945_CR9","doi-asserted-by":"publisher","first-page":"10743","DOI":"10.1073\/pnas.1708914114","volume":"114","author":"T Mazor","year":"2017","unstructured":"Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proc Natl Acad Sci U S A. 2017;114(40):10743\u20138. https:\/\/doi.org\/10.1073\/pnas.1708914114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"945_CR10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, et al. Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor. Cell. 2018;175(6):1665-78.e18. https:\/\/doi.org\/10.1016\/j.cell.2018.09.038.","journal-title":"Cell"},{"issue":"3","key":"945_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, et al. Integrated proteogenomic characterization of human High-Grade Serous Ovarian Cancer. Cell. 2016;166(3):755\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.05.069.","journal-title":"Cell"},{"issue":"7518","key":"945_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513(7518):382\u20137. https:\/\/doi.org\/10.1038\/nature13438.","journal-title":"Nature"},{"issue":"7605","key":"945_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534(7605):55\u201362. https:\/\/doi.org\/10.1038\/nature18003.","journal-title":"Nature"},{"issue":"10","key":"945_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 classification of Central Nervous System tumors and implications for therapy for Adult-Type Gliomas: a review. JAMA Oncol. 2022;8(10):1493\u2013501. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2844.","journal-title":"JAMA Oncol"},{"issue":"2","key":"945_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2967\/jnumed.118.212365","volume":"60","author":"S Xu","year":"2018","unstructured":"Xu S, Catapang A, Doh HM, Bayley NA, Lee JT, Braas D, et al. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin. J Nucl Med. 2018;60(2):212\u20137. https:\/\/doi.org\/10.2967\/jnumed.118.212365.","journal-title":"J Nucl Med"},{"key":"945_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094716","author":"F Ciscato","year":"2021","unstructured":"Ciscato F, Ferrone L, Masgras I, Laquatra C, Rasola A. Hexokinase 2 in cancer: a prima donna playing multiple characters. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094716.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"945_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188616. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188616.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"945_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/neuonc\/noab003","volume":"23","author":"S Wu","year":"2021","unstructured":"Wu S, Li X, Gao F, de Groot JF, Koul D, Yung WKA. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. Neuro Oncol. 2021;23(6):920\u201331. https:\/\/doi.org\/10.1093\/neuonc\/noab003.","journal-title":"Neuro Oncol"},{"issue":"8","key":"945_CR19","first-page":"1343","volume":"8","author":"Y Li","year":"2018","unstructured":"Li Y, Gan S, Ren L, Yuan L, Liu J, Wang W, et al. Multifaceted regulation and functions of replication factor C family in human cancers. Am J Cancer Res. 2018;8(8):1343\u201355.","journal-title":"Am J Cancer Res"},{"key":"945_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78253","author":"M Schrecker","year":"2022","unstructured":"Schrecker M, Castaneda JC, Devbhandari S, Kumar C, Remus D, Hite RK. Multistep loading of a DNA sliding clamp onto DNA by replication factor C. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.78253.","journal-title":"Elife"},{"issue":"6","key":"945_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tig.2024.02.006","volume":"40","author":"S Kang","year":"2024","unstructured":"Kang S, Yoo J, Myung K. PCNA cycling dynamics during DNA replication and repair in mammals. Trends Genet. 2024;40(6):526\u201339. https:\/\/doi.org\/10.1016\/j.tig.2024.02.006.","journal-title":"Trends Genet"},{"issue":"1","key":"945_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22971-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Tao T, Liu S, Yang X, Chen X, Liang J, et al. An RFC4\/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness. Nat Commun. 2021;12(1):2693. https:\/\/doi.org\/10.1038\/s41467-021-22971-x.","journal-title":"Nat Commun"},{"issue":"6993","key":"945_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nature02585","volume":"429","author":"GD Bowman","year":"2004","unstructured":"Bowman GD, O\u2019Donnell M, Kuriyan J. Structural analysis of a eukaryotic sliding DNA clamp-clamp loader complex. Nature. 2004;429(6993):724\u201330. https:\/\/doi.org\/10.1038\/nature02585.","journal-title":"Nature"},{"key":"945_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020152","author":"M Alaa Eldeen","year":"2024","unstructured":"Alaa Eldeen M, Mamdouh F, Abdulsahib WK, Eid RA, Alhanshani AA, Shati AA, et al. Oncogenic potential of Replication Factor C Subunit 4: correlations with tumor progression and assessment of potential inhibitors. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17020152.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"945_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.gastro.2024.01.027","volume":"166","author":"Y Won","year":"2024","unstructured":"Won Y, Jang B, Lee SH, Reyzer ML, Presentation KS, Kim H, et al. Oncogenic fatty acid metabolism rewires energy supply chain in gastric carcinogenesis. Gastroenterology. 2024;166(5):772-86.e14. https:\/\/doi.org\/10.1053\/j.gastro.2024.01.027.","journal-title":"Gastroenterology"},{"issue":"Suppl 5","key":"945_CR26","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 2019;21(Suppl 5):v1\u2013100. https:\/\/doi.org\/10.1093\/neuonc\/noz150.","journal-title":"Neuro Oncol"},{"key":"945_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9050052","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal Growth Factor Receptor cell proliferation signaling pathways. Cancers (Basel). 2017. https:\/\/doi.org\/10.3390\/cancers9050052.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"945_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z.","journal-title":"Signal Transduct Target Ther"},{"key":"945_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083883","author":"T de Los Reyes Corrales","year":"2021","unstructured":"de Los Reyes Corrales T, Losada-P\u00e9rez M, Casas-Tint\u00f3 S. JNK pathway in CNS pathologies. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22083883.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"945_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u201349. https:\/\/doi.org\/10.1038\/nrc2694.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"945_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12964-024-01809-1","volume":"22","author":"VJ Iyer","year":"2024","unstructured":"Iyer VJ, Donahue JE, Osman MA. Role of scaffold proteins in the heterogeneity of glioblastoma. Cell Commun Signal. 2024;22(1):477. https:\/\/doi.org\/10.1186\/s12964-024-01809-1.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"945_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/neuonc\/noad195","volume":"26","author":"J Fangusaro","year":"2024","unstructured":"Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, et al. Pediatric low-grade glioma: state-of-the-art and ongoing challenges. Neuro Oncol. 2024;26(1):25\u201337. https:\/\/doi.org\/10.1093\/neuonc\/noad195.","journal-title":"Neuro Oncol"},{"issue":"8","key":"945_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/neuonc\/noae074","volume":"26","author":"P O'Hare","year":"2024","unstructured":"O\u2019Hare P, Cooney T, de Blank P, Gutmann DH, Kieran M, Milde T, et al. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: a modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. Neuro Oncol. 2024;26(8):1357\u201366. https:\/\/doi.org\/10.1093\/neuonc\/noae074.","journal-title":"Neuro Oncol"},{"key":"945_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2020.09.036","volume":"154","author":"J Biau","year":"2021","unstructured":"Biau J, Thivat E, Chautard E, Stefan D, Boone M, Chauffert B, et al. Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma. Radiother Oncol. 2021;154:227\u201334. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.036.","journal-title":"Radiother Oncol"},{"issue":"6","key":"945_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/abbs\/gmw035","volume":"48","author":"Q Wang","year":"2016","unstructured":"Wang Q, Du J, Xu B, Xu L, Wang X, Liu J, et al. Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway. Acta Biochim Biophys Sin. 2016;48(6):501\u20138. https:\/\/doi.org\/10.1093\/abbs\/gmw035.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"3","key":"945_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2159-8290.Cd-20-1474","volume":"11","author":"JG Nicholson","year":"2021","unstructured":"Nicholson JG, Fine HA. Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov. 2021;11(3):575\u201390. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1474.","journal-title":"Cancer Discov"},{"issue":"4","key":"945_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1200\/jco.21.02036","volume":"40","author":"NA Mohile","year":"2022","unstructured":"Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, et al. Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline. J Clin Oncol. 2022;40(4):403\u201326. https:\/\/doi.org\/10.1200\/jco.21.02036.","journal-title":"J Clin Oncol"},{"issue":"1","key":"945_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03348-2","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Gao X, Yi J, Sang X, Dai Z, Tao Z, et al. BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C. Cell Death Dis. 2021;12(1):12. https:\/\/doi.org\/10.1038\/s41419-020-03348-2.","journal-title":"Cell Death Dis"},{"issue":"3","key":"945_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mdr2.70040","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Jiang A, Zhang Y, Wang Q, Li Z, et al. Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med Res. 2025;1(3):397\u2013411. https:\/\/doi.org\/10.1002\/mdr2.70040.","journal-title":"Med Res"},{"issue":"1","key":"945_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2.","journal-title":"NPJ Digit Med"},{"issue":"6","key":"945_CR41","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37(6):1000\u201319. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.06.11.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"945_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28. https:\/\/doi.org\/10.1186\/s12943-021-01316-8.","journal-title":"Mol Cancer"},{"key":"945_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020. https:\/\/doi.org\/10.1126\/science.aaw5473.","journal-title":"Science"},{"issue":"5930","key":"945_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"issue":"5","key":"945_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41556-023-01136-6","volume":"25","author":"K Papsdorf","year":"2023","unstructured":"Papsdorf K, Miklas JW, Hosseini A, Cabruja M, Morrow CS, Savini M, et al. Lipid droplets and peroxisomes are co-regulated to drive lifespan extension in response to mono-unsaturated fatty acids. Nat Cell Biol. 2023;25(5):672\u201384. https:\/\/doi.org\/10.1038\/s41556-023-01136-6.","journal-title":"Nat Cell Biol"},{"key":"945_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129921","author":"Z Guo","year":"2023","unstructured":"Guo Z, Bergeron KF, Lingrand M, Mounier C. Unveiling the MUFA-cancer connection: insights from endogenous and exogenous perspectives. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24129921.","journal-title":"Int J Mol Sci"},{"issue":"44","key":"945_CR47","doi-asserted-by":"publisher","first-page":"31844","DOI":"10.1074\/jbc.M706818200","volume":"282","author":"P Maliekal","year":"2007","unstructured":"Maliekal P, Sokolova T, Vertommen D, Veiga-da-Cunha M, Van Schaftingen E. Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family. J Biol Chem. 2007;282(44):31844\u201351. https:\/\/doi.org\/10.1074\/jbc.M706818200.","journal-title":"J Biol Chem"},{"key":"945_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102018","volume":"88","author":"MS Safari","year":"2024","unstructured":"Safari MS, Woerl P, Garmsiri C, Weber D, Kwiatkowski M, Hotze M, et al. Glucose-1,6-bisphosphate: a new gatekeeper of cerebral mitochondrial pyruvate uptake. Mol Metab. 2024;88:102018. https:\/\/doi.org\/10.1016\/j.molmet.2024.102018.","journal-title":"Mol Metab"},{"issue":"1","key":"945_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-025-07580-6","volume":"16","author":"W Qin","year":"2025","unstructured":"Qin W, Chen B, Li X, Zhao W, Wang L, Zhang N, et al. Cancer-associated fibroblasts secrete CSF3 to promote TNBC progression via enhancing PGM2L1-dependent glycolysis reprogramming. Cell Death Dis. 2025;16(1):249. https:\/\/doi.org\/10.1038\/s41419-025-07580-6.","journal-title":"Cell Death Dis"},{"issue":"50","key":"945_CR50","doi-asserted-by":"publisher","first-page":"35741","DOI":"10.1074\/jbc.274.50.35741","volume":"274","author":"ZG Han","year":"1999","unstructured":"Han ZG, Zhang QH, Ye M, Kan LX, Gu BW, He KL, et al. Molecular cloning of six novel Kr\u00fcppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB. J Biol Chem. 1999;274(50):35741\u20138. https:\/\/doi.org\/10.1074\/jbc.274.50.35741.","journal-title":"J Biol Chem"},{"issue":"18","key":"945_CR51","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1158\/0008-5472.Can-07-1617","volume":"67","author":"J Harper","year":"2007","unstructured":"Harper J, Yan L, Loureiro RM, Wu I, Fang J, D\u2019Amore PA, et al. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. Cancer Res. 2007;67(18):8736\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-1617.","journal-title":"Cancer Res"},{"issue":"9","key":"945_CR52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41419-021-04119-3","volume":"12","author":"W Li","year":"2021","unstructured":"Li W, Han S, Hu P, Chen D, Zeng Z, Hu Y, et al. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3\/ZNF24\/VEGFA pathway. Cell Death Dis. 2021;12(9):830. https:\/\/doi.org\/10.1038\/s41419-021-04119-3.","journal-title":"Cell Death Dis"},{"issue":"9","key":"945_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07075-w","volume":"15","author":"T Wen","year":"2024","unstructured":"Wen T, Zhang X, Gao Y, Tian H, Fan L, Yang P. SOX4-BMI1 axis promotes non-small cell lung cancer progression and facilitates angiogenesis by suppressing ZNF24. Cell Death Dis. 2024;15(9):698. https:\/\/doi.org\/10.1038\/s41419-024-07075-w.","journal-title":"Cell Death Dis"},{"issue":"1","key":"945_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00933-0","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Lei Y, Chen W, Zhou Q, Zheng Z, Zeng G, et al. In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-\u03baB modulator in lung cancer. Cell Biosci. 2022;12(1):193. https:\/\/doi.org\/10.1186\/s13578-022-00933-0.","journal-title":"Cell Biosci"},{"issue":"6","key":"945_CR55","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","volume":"28","author":"L Niu","year":"2022","unstructured":"Niu L, Thiele M, Geyer PE, Rasmussen DN, Webel HE, Santos A, et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat Med. 2022;28(6):1277\u201387. https:\/\/doi.org\/10.1038\/s41591-022-01850-y.","journal-title":"Nat Med"},{"issue":"W1","key":"945_CR56","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321. https:\/\/doi.org\/10.1093\/nar\/gkac194.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"945_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"945_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2022;1(3):e36. https:\/\/doi.org\/10.1002\/imt2.36.","journal-title":"Imeta"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00945-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:45:01Z","timestamp":1776339901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00945-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00945-8","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The acquisition of samples was approved by the Ethics Committee of Zhujiang Hospital of Southern Medical University (2025-SJWK-004). The study was conducted according to the principles of the Declaration of Helsinki. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}